A 12-month phase 3 study of pasireotide in Cushing's disease.
Colao A; Petersenn S; Newell-Price J; Findling JW; Gu F; Maldonado M; Schoenherr U; Mills D; Salgado LR; Biller BM; The New England Journal Of Medicine, 2012, vol. 366, issue 10, p 914, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation